ArticleJournal of cancer research and clinical oncology2019

Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry).

Susanne Möbius et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.